Skip to main content

Table 4 Multivariate binary logistic regression to evaluate non responsiveness to ESAs between the 2nd and the 6th month after ID in cancer patients

From: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study

 

Non responsiveness

ΔHb < 0 g/dL (at least once)

OR (95% CI)

P-value

Baseline Hb (g/dL)

1.7 (1.1–2.4)

0.007

Comorbidities

 Ischemic heart disease

2.7 (0.9–7.9)

0.072

Laboratory Values

 Albumin (g/dL)

0.7 (0.5–1.1)

0.091

 Potassium (mEq/L)

0.7 (0.4–1.0)

0.063

 CRP (mg/dL)

1.1 (0.9–1.3)

0.537

  1. Covariates as ferritin and vitamin B12 levels were excluded because of the high proportion of missing values (> 40%)
  2. Cancer ESA users starting the treatment at baseline Hb ≥ 11 g/dL were excluded